Sanna Iivanainen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Low Density Lipoprotein

Advanced Cancer

Squamous Cell Carcinoma

Top Venues

Journal of medical Internet research

Cancer reports (Hoboken, N.J.)

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Abdul Rafeh Naqash, Justin D McCallen, Emma Mi, Sanna Iivanainen, Mona A Marie, Daria Gramenitskaya, James Clark, Jussi Pekka Koivunen, Shravanti Macherla, Sweta Jonnalagadda, Shanker Polsani, Rahim Ali Jiwani, Maida Hafiz, Mahvish Muzaffar, Leonardo Brunetti, Chipman R G Stroud, Paul R Walker, Kun Wang, Youngmin Chung, Eytan Ruppin, Se-Hoon Lee, Li V Yang, David James Pinato, Joo Sang Lee, Alessio Cortellini
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer. Journal for immunotherapy of cancer 11 (10) (2023)
Otto Manninen, Laura Puuniemi, Sanna Iivanainen, Martti Arffman, Riitta Kaarteenaho, Jussi Pekka Koivunen
Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study. Acta oncologica (Stockholm, Sweden) (2023)
Sanna Iivanainen, Anne-Marie Baird, Bogdana Balas, Alberto Bustillos, Amparo Yovanna Castro Sanchez, Manuela Eicher, Sophie Golding, Mathis Mueller-Ohldach, Maria Reig, Manfred Welslau, Johannes U Ammann
Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study (ORIGAMA). BMJ open 13 (4) (2023)
Saara Kuusisalo, Antti Tikkanen, Elisa Lappi-Blanco, Timo Väisänen, Aija Knuuttila, Satu Tiainen, Jarkko Ahvonen, Sanna Iivanainen, Jussi P Koivunen
The prognostic and predictive roles of plasma C-reactive protein and PD-L1 in non-small cell lung cancer. Cancer medicine (2023)
Saara Kuusisalo, Jussi P Koivunen, Sanna Iivanainen
Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study. Cancers 14 (9) (2022)
Anna Jokimäki, Sanna Iivanainen, Raija Mikkonen, Kallio Mika, Jussi Pekka Koivunen
Assessment of chemotherapy-induced neurotoxicity using a point-of-care nerve conduction study device. Cancer reports (Hoboken, N.J.) (2022)
Sanna Iivanainen, Tuomo Alanko, Pia P Vihinen, Teemu Konkola, Jussi Ekstrom, Henri Virtanen, Jussi Pekka Koivunen
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study. JMIR formative research 4 (10) (2020)
Oliver Schmalz, Christine Jacob, Johannes U Ammann, Blasius Janusch Liss, Sanna Iivanainen, Manuel Kammermann, Jussi Pekka Koivunen, Alexander Klein, Razvan Andrei Popescu
Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients. Journal of medical Internet research 22 (12) (2020)